Rheumatoid arthritis Trials in Newmarket, Canada
Conditions / Rheumatoid arthritis / Newmarket, Canada
Clinical trials for Rheumatoid arthritis investigate a range of treatment strategies and patient populations.
19 total trials for this combination
Showing top 10 of 19 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01061736 | Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients | COMPLETED | PHASE2/PHASE3 |
| NCT00106522 | A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy | COMPLETED | PHASE3 |
| NCT00717236 | Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT00647270 | Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing | COMPLETED | PHASE3 |
| NCT00106548 | A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT02198651 | A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects | COMPLETED | PHASE4 |
| NCT00422383 | A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA) | COMPLETED | PHASE3 |
| NCT00175877 | A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT00195702 | Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate. | COMPLETED | PHASE3 |
| NCT00152386 | A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid Arthritis | COMPLETED | PHASE3 |